Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-1995 | 07-1995 | 04-1995 | 01-1995 | 10-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20 | 20 | 20 | N/A | 20 |
| Marketable Securities | 80 | 100 | 130 | N/A | 120 |
| Receivables | 8 | 90 | 40 | N/A | 10 |
| Inventories | 50 | 30 | 80 | N/A | 40 |
| Other current assets | 12 | 30 | -30 | 0 | 20 |
| TOTAL | $170 | $270 | $240 | $N/A | $210 |
| Non-Current Assets | |||||
| PPE Net | 1,084 | 1,084 | N/A | N/A | N/A |
| Other Non-Current Assets | 10 | 10 | 10 | 0 | 10 |
| TOTAL | $1,094 | $1,094 | $10 | $N/A | $10 |
| Total Assets | $700 | $820 | $800 | $N/A | $830 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 70 | 70 | 120 | 0 | 470 |
| Accrued Expenses | 30 | 30 | 40 | N/A | 40 |
| Other current liabilities | 70 | 190 | 140 | N/A | 60 |
| TOTAL | $200 | $320 | $330 | $N/A | $630 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30 | 30 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 30 | 30 | 0 | 0 | 10 |
| TOTAL | $60 | $60 | $30 | $N/A | $10 |
| Total Liabilities | $260 | $400 | $360 | $N/A | $650 |
| Shareholders' Equity | |||||
| Common Shares | 7 | 7 | 7 | N/A | 7 |
| Retained earnings | -5,380 | -5,400 | -5,420 | N/A | -5,640 |
| Other shareholders' equity | 563 | 563 | 563 | 0 | 563 |
| TOTAL | $430 | $410 | $390 | $N/A | $170 |
| Total Liabilities And Equity | $690 | $810 | $750 | $0 | $820 |